News

India Business News: Biocon has decided to set up a Rs 1,000-crore manufacturing facility at Jawahar Pharma City, a special economic zone (SEZ) near Visakhapatnam.
Biopharmaceuticals company, Biocon, is planning to set up a manufacturing facility in Visakahapatnam in the next six months, according to its chairperson and MD Kiran Mazumdar Shaw.
Indian biopharma company Biocon reported third-quarter revenue on Thursday that fell about 3% when compared with the year-earlier period, which included revenue from its domestic branded ...
Biocon and Eris have expanded a previous agreement, with Biocon selling Indian branded formulations businesses to Mumbai-based Eris for $150M.
Biocon said the proceeds from the QIP will be utilised for purchase of outstanding optionally convertible debentures issued by its subsidiary.
In a filing to the stock exchange, Biocon stated, "The U.S. Food and Drug Administration (USFDA) concluded a GMP inspection of our API facility (Site 6), located at Visakhapatnam, Andhra Pradesh ...
Shares of Biocon were up 1.7% at ₹348.35 on Thursday, after falling 4.3% in the previous two sessions. The pharma company is looking to raise ₹4,500 crore through a qualified institutional ...
As we previously reported, in December 2022, Biocon Biologics Ltd. (a subsidiary of Biocon Ltd.) had completed acquisition of the global biosimilars business of its long-term partner Viatris, Inc ...
Biocon has named Peter Bains, who led the Indian drugmaker’s CRO Syngene through its public offering in 2015, Biocon Group chief executive as the company looks to expand its presence in emerging ...
Biocon Biologics and Regeneron executed the settlement agreement to dismiss the pending appeal at the United States Court of Appeals for the Federal Circuit (USCAFC) of patent US11084865 ('865 ...
Indian drugmaker Biocon , looking to grab a piece of the exploding weight-loss drug market as early as possible, is developing its own version of Novo Nordisk's wildly popular Wegovy and is ...
Biocon to set up a unit near Vizag By Our Bureau Updated - March 12, 2018 at 09:30 PM.